V-Med RETATRUTIDE 30 mg
Retatrutide is an investigational peptide that activates three hormone receptors in the body namely the glucagon-like peptide-1 receptor the glucose-dependent insulinotropic peptide receptor and the glucagon receptor. It has been developed to help with metabolic regulation weight management and improvements in glucose homeostasis. 
Clinical trials have shown that Retatrutide delivers strong reductions in body weight over time together with better metabolic markers in overweight or obese individuals.
CATEGORY: Growth Hormones / Peptides
1 vial in a box /30mg strength per vial 
Properties & Effects
Encourages significant weight loss percentages in long term use especially at higher dosages
Improves insulin sensitivity glucose control and blood sugar regulation
Supports reduced appetite increased satiety and lower caloric intake
Enhances energy expenditure and metabolic rate
May improve lipid profile inflammation markers and cardiovascular risk factors PMC+2nejm.org+2
Mechanism of Action
Retatrutide works by binding to and stimulating the GLP-1 GIP and glucagon receptors simultaneously. This multi-receptor agonism means that Retatrutide helps reduce food intake by prolonging feelings of fullness slows gastric emptying elevates energy usage by modulating glucagon action and supports insulin secretion when glucose levels are high. It also influences pathways involved in fat metabolism and thermogenesis. nejm.org+2Wikipedia+2
Recommended Use
Typical usage in research settings is once-weekly injections by subcutaneous route. The dose often starts low and increases gradually to allow the body to adapt and to reduce side effects. For example trials have begun with doses around 1-2 mg weekly and increased to higher levels like 8-12 mg weekly depending on tolerance and individual response. IAPAM+2Amazing Meds+2
For the 10 mg vial option one could use it for shorter cycles or as a part of dose-escalation protocol. The 30 mg vial provides room for higher dose regimens or more flexibility. Combine with diet modifications activity and other metabolic support like hydration micronutrients and possibly other peptides or compounds under supervision.
Safety & Side Effects
Retatrutide is generally well tolerated in controlled studies. Common adverse effects include gastrointestinal discomfort (nausea vomiting diarrhoea) especially during the initial weeks or when doses increase. These effects tend to lessen over time as the body adjusts. Amazing Meds+2GoodRx+2
Some risk of hypoglycemia exists when used together with other glucose lowering agents. Monitoring of blood sugar lipid profile liver function and overall metabolic health is advised. As with any peptide therapy sterility of preparation route of administration and quality of product matter very much.
Special Notes
Results are cumulative they build over weeks to months and the highest efficacy is often observed after extended use beyond 24-48 weeks in clinical trials. This product is investigational not yet approved by many regulatory authorities for general use. Pregnant breastfeeding individuals or those with severe underlying medical conditions should not use without medical supervision.
Dosage Calculator
MEN - RECOMMENDED DOSAGES
For weeks 1–4: Start with 2 mg (0.13 mL or 13 units) to assess tolerance.
For weeks 5–8: Increase to 4 mg (0.27 mL or 27 units) if well-tolerated.
For weeks 9–12: Move to 8 mg (0.53 mL or 53 units) for maintenance toward weight loss goals.
WOMEN - RECOMMENDED DOSAGES
For weeks 1–4: Start with 0.75 mg (0.5 mL or 5 units) up until 1.5 mg to assess tolerance.
For weeks 5–8: Increase to 1.5 mg (0.10 mL or 10 units) up until 2.5 mg if well-tolerated.
For weeks 9–12: Move to 2.5 mg (0.17 mL or 17 units) up until 3 mg for maintenance toward weight loss goals.